Risk and Response Adapted Treatment Guidelines for Managing First Relapsed and Refractory Classical Hodgkin Lymphoma in Children and Young People. Recommendations from the EuroNet Pediatric Hodgkin Lymphoma Group.

Hemasphere · 2020 · PMC7000476 · PMID 32072145

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

Time to relapse: It is defined from completion of first line treatment and is the most important prognostic factor at the point of relapse and highly significant for OS and EFS in pediatric studies dominating all other prognostic factors in multivariate analysis of the ST-HD-86 study (p 0.0001) for example.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.